Oncology and Hematology News and Journal Articles
Cancer Network presents exclusive coverage from the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. We’ll bring you reports and interviews of the latest research, trials, scientific advances, and controversies that are changing the way cancer is managed and treated.
Researchers have discovered a protein encoded by the GPC1 gene present on cancer exomes that may be used as a diagnostic tool to detect early pancreatic cancer.
Detection of cervical lesions among young women has decreased since the introduction of HPV vaccines and guidelines calling for reduced cervical cancer screening.
Women with ovarian cancer with ADAMTS mutations were significantly more sensitive to chemotherapy and had longer platinum-free durations.
Survivors of thyroid cancer had a higher risk of unemployment at 2 years post-diagnosis and decreased income at both 2 and 4 years, according to the results of a study.
New data suggests that cutaneous melanomas can be classified into four subtypes based on the pattern of the most prevalent significantly mutated genes.
Some of the most brilliant physicians I have known have impressed me with their respect for colleagues. They would never express a difference of opinion by denigrating another practitioner, but recent experiences have opened my eyes to the arrogance of some physicians.
A study of men taking PDE5 inhibitors found a small but significant increase in the incidence of malignant melanoma, though the association may not be causal.
In this video, Dr. Paz-Ares discusses a phase III study that showed that nivolumab improved survival and response rates in previously treated patients with metastatic non-squamous non-small-cell lung cancer (NSCLC).
In this video, Steven I. Sherman, MD, discusses the final overall survival analysis of the EXAM study, a randomized, placebo-controlled phase III trial of cabozantinib in medullary thyroid carcinoma patients.
In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
In this video, Dr. Tap discusses a randomized phase Ib/II trial that found that adding olaratumab to doxorubicin dramatically improved survival in patients with advanced soft-tissue sarcoma.
This thyroid cancer slide show features pathology images of follicular carcinoma and Hurthle cell carcinoma at various magnifications.
This slide show features various magnifications of tumors of the middle ear, including a endolymphatic sac tumor, a meningioma, and a paraganglioma.